Vaccination Archives - Healthed

Vaccination

Vaccination

A/Prof Nicholas Wood

Clinical Articles

Babies can get hepatitis B at birth. Here’s why Trump is wrong about delaying the vaccine

Expert/s: A/Prof Nicholas Wood, Prof Kristine Macartney, Dr Lucy Deng

Vaccination

Christopher Blyth

Clinical Articles

Prevenar 20 has replaced other pneumococcal vaccines on NIP

Here's what you need to know about efficacy, safety, dosing schedule and more...

Expert/s: Christopher Blyth, Sanjay Jayasinghe

Infectious diseases, Public health, Respiratory and sleep, Vaccination

Prof Paul Griffin

Videos

Rapid update: Respiratory viruses and vaccination

In this short video, Prof Paul Griffin provides an update on respiratory viruses, emphasising the critical need to increase vaccination uptake, particularly for COVID-19, Influenza and Respiratory syncytial virus (RSV), and the need for healthcare professionals to actively promote and facilitate co-administration.

Expert/s: Prof Paul Griffin

Drugs and devices, Geriatric medicine, Infectious diseases, Vaccination

Prof Andrew Sindone

Videos

Updated indications for the recombinant, adjuvanted RSV vaccine

In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.

Expert/s: Prof Andrew Sindone

Cardiology, Respiratory and sleep, Vaccination

Prof Andrew Sindone

Podcasts

RSV and the heart

Professor Andrew Sindone discusses the potentially deadly combination of RSV and cardiac disease.

Expert/s: Prof Andrew Sindone

Paediatrics, Vaccination

A/Prof Daryl Cheng

Podcasts

RSV prevention in infants and pregnant women

A/Prof Daryl Cheng outlines the details of the new RSV vaccination program.

Expert/s: A/Prof Daryl Cheng

Geriatric medicine, Infectious diseases, Obstetrics and gynaecology, Vaccination

Prof Paul Griffin

Videos

Recombinant respiratory syncytial virus pre-fusion F protein vaccine

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Expert/s: Prof Paul Griffin

Drugs and devices, Geriatric medicine, Infectious diseases, Vaccination

Prof Michael Woodward AM

Videos

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

Expert/s: Prof Michael Woodward AM

Paediatrics, Vaccination

A/Prof Christopher Blyth

Clinical Articles

Babies in WA will soon be immunised against RSV

All WA babies under eight months old, as well as those aged eight to 19 months at increased risk of severe RSV infection, will be eligible for monoclonal antibodies.

Expert/s: A/Prof Christopher Blyth, Prof Allen Cheng

Vaccination

Clinical Articles

Health misinformation is rampant on social media

The global anti-vaccine movement and vaccine hesitancy that accelerated during the COVID-19 pandemic show no signs of abating...

Expert/s: Dr Monica Wang

Vaccination

Lynnette Hoffman

Clinical Articles

Three RSV vaccines coming

What we know about the RSV vaccines so far...

Expert/s: Lynnette Hoffman

Drugs and devices, Infectious diseases, Vaccination

Prof Paul Van Buynder

Videos

New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3

In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Expert/s: Prof Paul Van Buynder